Monoclonal antibodies in haemato-oncology (Record no. 76009)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02365ngm a2200469 a 4500 |
001 - CONTROL NUMBER | |
control field | HST5218 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | UkLoHST |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m c |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr|cna|||a|||| |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | vz|czazum |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200604s2020 enk|||||||||||s|||v|eng d |
028 50 - PUBLISHER NUMBER | |
Publisher number | 5218 |
Source | Henry Stewart Talks |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (UkLoHST)4266 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | UkLoHST |
Language of cataloging | eng |
Transcribing agency | UkLoHST |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Cragg, Mark, |
Affiliation | (University of Southampton, UK) |
Relator code | spk |
245 10 - TITLE STATEMENT | |
Title | Monoclonal antibodies in haemato-oncology |
Medium | [electronic resource] / |
Statement of responsibility, etc. | Mark Cragg. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc. | London : |
Name of publisher, distributor, etc. | Henry Stewart Talks, |
Date of publication, distribution, etc. | 2020. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (1 streaming video file (45 min.) : |
Other physical details | color, sound). |
490 1# - SERIES STATEMENT | |
Series statement | Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances, |
International Standard Serial Number | 2056-452X |
500 ## - GENERAL NOTE | |
General note | Animated audio-visual presentation with synchronized narration. |
500 ## - GENERAL NOTE | |
General note | Title from title frames. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Contents: Introduction to the development and clinical use of monoclonal antibodies (mAb) in haemato-oncology -- Currently approved mAb for treating cancer -- Direct targeting antibodies -- Rituximab -- Fc gamma receptors (FcgR) as key mediators of cellular immunity -- Macrophages as key effector cells -- B cell deletion as a paradigm for mAb effects -- Type I versus Type II antibodies -- Obinutuzumab -- Immunomodulatory mAb -- Combinations between direct targeting and immunomodulatory mAb. |
506 ## - RESTRICTIONS ON ACCESS NOTE | |
Terms governing access | Access restricted to subscribers. |
538 ## - SYSTEM DETAILS NOTE | |
System details note | Mode of access: World Wide Web. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Antineoplastic agents. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Lymphoma |
General subdivision | Chemotherapy. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Monoclonal antibodies. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Antibodies, Monoclonal |
General subdivision | therapeutic use. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Antineoplastic Agents |
General subdivision | pharmacology. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Antineoplastic Agents, Immunological. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | B-Lymphocytes. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Immunity, Cellular. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Lymphoma |
General subdivision | drug therapy. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Macrophages. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | obinutuzumab. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Receptors, IgG |
General subdivision | drug effects. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Receptors, IgG |
General subdivision | metabolism. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Rituximab |
General subdivision | phamacology. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Henry Stewart talks. |
Name of part/section of a work | Biomedical & life sciences collection. |
-- | Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances. |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://hstalks.com/bs/4266/">https://hstalks.com/bs/4266/</a> |
856 42 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://hstalks.com/bs/p/30/">https://hstalks.com/bs/p/30/</a> |
Materials specified | Series |
No items available.